Supernus Pharmaceuticals
SUPN
$30.07
Share price
2.59%
Change (1 day)
-18.42%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.35 B
According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are $0.35 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.35 B | -56.37% |
| 2022-12-31 | $0.81 B | -6.53% |
| 2021-12-31 | $0.87 B | 15.02% |
| 2020-12-31 | $0.75 B | 34.41% |
| 2019-12-31 | $0.56 B | 7.63% |
| 2018-12-31 | $0.52 B | 234.29% |
| 2017-12-31 | $0.15 B | 33.25% |
| 2016-12-31 | $0.11 B | 17.09% |
| 2015-12-31 | $0.10 B | 4.72% |
| 2014-12-31 | $96.08 M | 23.93% |
| 2013-12-31 | $77.53 M | 112.89% |
| 2012-12-31 | $36.41 M | -17.77% |
| 2011-12-31 | $44.28 M | -51.51% |
| 2010-12-31 | $91.32 M | 6.13% |
| 2009-12-31 | $86.05 M | 2.59% |
| 2008-12-31 | $83.88 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 27,636.08% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | 9,555.01% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | 14,821.12% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 23,059.17% | 🇺🇸 USA |
 United Therapeutics UTHR | $1.18 B | 231.93% | 🇺🇸 USA |